Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.


HHS - 31442 - Advisory Council on Blood Stem Cell Transplantation - Statutory (Congress Created)
Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NameAdvisory Council on Blood Stem Cell TransplantationAgency NameDepartment of Health and Human Services
Fiscal Year2020Committee Number31442
Original Establishment Date12/20/2005Committee StatusChartered
Actual Termination Date Committee URLhttps://bloodcell.transplant.hrsa.gov/about/adv...
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*25
Current Charter Date2/19/2019Designated Fed Officer Position Title*Senior Advisor, Division of Transplantation, HSB
Date Of Renewal Charter2/19/2021Designated Federal Officer PrefixMr.
Projected Termination Date Designated Federal Officer First Name*Robert
Exempt From Renewal*NoDesignated Federal Officer Middle Name
Specific Termination AuthorityDesignated Federal Officer Last Name*Walsh
Establishment Authority*Statutory (Congress Created)Designated Federal Officer Suffix
Specific Establishment Authority*42 U.S.C. 274kDesignated Federal Officer Phone*(301) 443-6839
Effective Date Of Authority*12/20/2005Designated Federal Officer Fax*301-594-6095
Exempt From EO 13875 Discretionary CmteNot ApplicableDesignated Federal Officer Email*rwalsh@hrsa.gov
Committee Type*Continuing
Presidential*No
Committee Function*Non Scientific Program Advisory Board
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The ACBSCT was established to advise the Secretary of HHS on matters related to the activities of the C.W. Bill Young Cell Transplantation and the National Cord Blood Inventory Programs. The ACBSCT provides a consolidated, comprehensive source of expert, unbiased analysis and recommendations to the Secretary on the latest advances in the science of blood stem cell transplantation, including cord blood.
How is membership balanced?*The Council is composed of up to 25 voting members representing marrow donor and transplant centers; cord blood banks; birthing hospitals; transplant recipients; persons waiting for transplants; family members of recipients; and members of the general public.
How frequent & relevant are cmte mtgs?*Meetings may be held up to three times during a fiscal year. There were two ACBSCT meeting in FY 2020.
Why advice can't be obtained elsewhere?*This expertise is not available within HHS.
Why close or partially close meetings?N/A
Recommendation Remarks
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*Yes
Outcome Trust In GovernmentYesAction Reallocate ResourcesNo
Outcome Major Policy ChangesYesAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchYesAction Proposed LegislationNo
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryYesAction OtherNo
Outcome Increased Customer SatisfactionYesAction CommentN/A
Outcome Implement Laws/Reg RequirementsYesGrants Review*No
Outcome OtherNoNumber Of Grants Reviewed0
Outcome CommentN/ANumber Of Grants Recommended0
Cost Savings*NoneDollar Value Of Grants Recommended$0.00
Cost Savings CommentWhile the ACBSCT's recommendations have focused on improvements to patient care through blood stem cell transplant and efficiency in the system, direct cost savings for the government have not been measured.Grants Review CommentN/A
Number Of Recommendations*33Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentOne recommendation was made in FY 2020Access Agency WebsiteYes
% of Recs Fully Implemented*48.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentThe Program and the community are engaged in discussions about the implementation of all recommendations.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*52.00%Access PublicationsNo
% of Recs Partially Implemented CommentThe Program and the community are engaged in discussions about the implementation of all recommendations.Access OtherNo
Agency Feedback*YesAccess CommentN/A
Agency Feedback Comment*The Secretary of HHS acknowledges receipt of the ACBSCT recommendations, and thanks the ACBSCT for providing advice and recommendations on the blood and stem cell transplantation issues. Status of recommendations is regularly reviewed with the advisory council.Narrative Description*HHS has a vital role in safeguarding and promoting public health by overseeing the operation of the C.W. Bill Young Transplantation Program and the National Cord Blood Inventory. The principal purpose of these programs is to make blood stem cells from adult donors and cord blood units available for patients who need a transplant to treat life-threatening conditions, such as leukemia, and who lack a suitably matched relative who can be the donor.
Hide Section - COSTS

COSTS

Payments to Non-Federal Members*$2,400.00Est Payments to Non-Fed Members Next FY*$4,000.00
Payments to Federal Members*$3,878.00Est. Payments to Fed Members Next FY*$4,000.00
Payments to Federal Staff*$110,926.00Estimated Payments to Federal Staff*$112,035.00
Payments to Consultants*$0.00Est. Payments to Consultants Next FY*$0.00
Travel Reimb. For Non-Federal Members*$0.00Est Travel Reimb Non-Fed Members nextFY*$6,000.00
Travel Reimb. For Federal Members*$0.00Est Travel Reimb For Fed Members*$0.00
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY*$0.00
Travel Reimb. For Consultants*$0.00Est Travel Reimb to Consultants Next FY*$0.00
Other Costs$73,991.00Est. Other Costs Next FY*$60,000.00
Total Costs$191,195.00Est. Total Next FY*$186,035.00
Federal Staff Support (FTE)*0.65Est. Fed Staff Support Next FY*0.65
Cost RemarksOther costs include logistics support for two virtual meetingsEst Cost RemarksOther costs include logistics support for one virtual meeting and one in-person meeting
Hide Section - Interest Areas

Interest Areas

Category
Area
Health
Safety
Treatment
Medicine
Diseases
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

 
ActionCommittee System IDCommittee NameFiscal Year
 COM-036426Advisory Council on Blood Stem Cell Transplantation2019
 COM-034632Advisory Council on Blood Stem Cell Transplantation2018
 COM-002045Advisory Council on Blood Stem Cell Transplantation2017
 COM-002314Advisory Council on Blood Stem Cell Transplantation2016
 COM-004043Advisory Council on Blood Stem Cell Transplantation2015
 COM-004782Advisory Council on Blood Stem Cell Transplantation2014
 COM-006225Advisory Council on Blood Stem Cell Transplantation2013
 COM-006633Advisory Council on Blood Stem Cell Transplantation2012
 COM-007961Advisory Council on Blood Stem Cell Transplantation2011
 COM-008733Advisory Council on Blood Stem Cell Transplantation2010
 COM-010380Advisory Council on Blood Stem Cell Transplantation2009
 COM-010675Advisory Council on Blood Stem Cell Transplantation2008
 COM-011979Advisory Council on Blood Stem Cell Transplantation2007